NexGel, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totaling 197,339 shares, a decrease of 50.1% from the August 31st total of 395,627 shares. Currently, 2.5% of the company’s stock are short sold. Based on an average trading volume of 243,093 shares, the days-to-cover ratio is currently 0.8 days.
NexGel Stock Performance
Shares of NXGL stock traded down $0.01 during trading hours on Tuesday, reaching $0.16. The company had a trading volume of 91,522 shares, compared to its average volume of 443,943. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.27 and a current ratio of 0.43. The business has a fifty day moving average price of $0.36 and a 200-day moving average price of $0.51. NexGel has a one year low of $0.16 and a one year high of $2.89. The firm has a market cap of $1.59 million, a PE ratio of -0.23 and a beta of 0.76.
NexGel (NASDAQ:NXGL – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.28). NexGel had a negative net margin of 51.26% and a negative return on equity of 121.18%. The company had revenue of $3.69 million for the quarter, compared to the consensus estimate of $4.32 million.
Analyst Ratings Changes
Read Our Latest Analysis on NXGL
Hedge Funds Weigh In On NexGel
An institutional investor recently bought a new position in NexGel stock. Empery Asset Management LP purchased a new position in NexGel, Inc. (NASDAQ:NXGL – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned about 0.98% of NexGel at the end of the most recent reporting period. Institutional investors and hedge funds own 2.21% of the company’s stock.
NexGel Company Profile
NexGel, Inc develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.
The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.
Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies.
See Also
- Five stocks we like better than NexGel
- NVIDIA Just Strengthened the Case for Its Massive Stock Price Upside
- Apple, Meta, and SpaceX Are Driving a Device Boom—These 3 Stocks Could Benefit
- 2 Short-Squeeze Candidates Waiting for the Right Catalyst
- MongoDB Stock Drops 17% After CEO Exit—What Investors Should Know
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
